CD44 and neoplasm: Earlier studies have shown that breast cancer cells contain stem-cell like cells exhibiting CD44+CD24-/low marker expression and these cells possess more than 50 fold increased tumorigenic capacity when compared to the other cells of tumour mass [13, 16, 22].